Bliss Kelly 4

What Happened Bliss Kelly, President, U.S. Group Health at Teladoc Health, reported a sale of 2,500 shares on July 6, 2026. The shares were disposed at $9.50 each for a total transaction value of $23,750. The filing lists the transaction as an open market or private sale (code S), i.e., a sale rather than a purchase.

Key Details

• Transaction date: July 6, 2026; Price per share: $9.50; Shares sold: 2,500; Total value: $23,750.
• Reported as: Sale (S) — described as "open market or private sale."
• Footnote: Trade was effected under a Rule 10b5-1 trading plan adopted August 14, 2025.
• Shares owned after the transaction: Not specified in the information provided.
• Timeliness: Reported on the same date as the transaction (no late filing indicated).

Context A Rule 10b5-1 plan indicates the sale was executed under a prearranged trading program, which is commonly used to schedule trades in advance and reduce concerns about trading on inside information. Sales are often routine and do not by themselves indicate the insider’s view of the company; purchases tend to be more informative for bullish signals.